News
Discover Piper Sandler's latest biotech oncology picks, ratings, and price targets. Gain expert insights on CGON, BCAX, DAWN, ...
With a forward-price-to-earnings multiple under 15x and significant hedge fund interest, ProPetro Holding Corp. (NYSE:PUMP) ...
6h
TipRanks on MSNDay One Biopharmaceuticals initiated with an Overweight at Piper Sandler
Piper Sandler initiated coverage of Day One Biopharmaceuticals (DAWN) with an Overweight rating and $25 price target Piper thinks the stock move ...
Netflix Inc. (NASDAQ:NFLX) is one of the best big tech stocks to buy right now. In a late-July note, Piper Sandler analyst ...
6h
TipRanks on MSNBicara Therapeutics initiated with an Overweight at Piper Sandler
Piper Sandler analyst Kelsey Goodwin initiated coverage of Bicara Therapeutics (BCAX) with an Overweight rating and $36 price target The firm’s channel checks highlighted a favorable view on Bicara’s ...
Detailed price information for Exxon Mobil Corp (XOM-N) from The Globe and Mail including charting and trades.
Piper Sandler analyst Ryan Todd maintained a Buy rating on Chevron today and set a price target of $168.00. The company’s shares closed last Friday at $156.55. Take advantage of TipRanks Premium at 50 ...
5d
Cryptopolitan on MSNPiper Sandler lifts Nvidia target to $225, sees 23% upside ahead of Q2 earnings
Piper Sandler has raised Nvidia’s price target from $180 to $225, calling for a 23% upside before the chipmaker reports Q2 ...
Piper Sandler raises Nvidia price target to $225, citing strong demand, supply constraints, and earnings optimism ahead of ...
ICU Medical (ICUI) stock climbs as Piper Sandler issues an overweight recommendation, citing a new product cycle wave for the company's infusion pumps. Read more here.
The investment bank signed a large lease at 1301 Sixth Avenue, joined shortly after by a law firm taking a smaller space.
Covering this stock for Piper Sandler, 5-star analyst Alexander Potter outlines the contours of Instacart’s market and addressable opportunity, writing, “As a result of the COVID-19 pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results